173 related articles for article (PubMed ID: 36209771)
1. Fast antidepressant action of ketamine in mouse models requires normal VGLUT1 levels from prefrontal cortex neurons.
Belloch FB; Cortés-Erice M; Herzog E; Zhang XM; Díaz-Perdigon T; Puerta E; Tordera RM
Prog Neuropsychopharmacol Biol Psychiatry; 2023 Mar; 121():110640. PubMed ID: 36209771
[TBL] [Abstract][Full Text] [Related]
2. Vesicular glutamate transporter 1 (VGLUT1)-mediated glutamate release and membrane GluA1 activation is involved in the rapid antidepressant-like effects of scopolamine in mice.
Yu H; Li M; Zhou D; Lv D; Liao Q; Lou Z; Shen M; Wang Z; Li M; Xiao X; Zhang Y; Wang C
Neuropharmacology; 2018 Mar; 131():209-222. PubMed ID: 29274366
[TBL] [Abstract][Full Text] [Related]
3. SIRT2 inhibition reverses anhedonia in the VGLUT1+/- depression model.
Muñoz-Cobo I; Belloch FB; Díaz-Perdigón T; Puerta E; Tordera RM
Behav Brain Res; 2017 Sep; 335():128-131. PubMed ID: 28778545
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: effects of fluoxetine and MK-801.
Farley S; Dumas S; El Mestikawy S; Giros B
Neuropharmacology; 2012 Jan; 62(1):503-17. PubMed ID: 21945287
[TBL] [Abstract][Full Text] [Related]
5. Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression.
Zhang JC; Yao W; Dong C; Yang C; Ren Q; Ma M; Han M; Hashimoto K
Psychopharmacology (Berl); 2015 Dec; 232(23):4325-35. PubMed ID: 26337614
[TBL] [Abstract][Full Text] [Related]
6. Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression.
Yang B; Zhang JC; Han M; Yao W; Yang C; Ren Q; Ma M; Chen QX; Hashimoto K
Psychopharmacology (Berl); 2016 Oct; 233(19-20):3647-57. PubMed ID: 27488193
[TBL] [Abstract][Full Text] [Related]
7. The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice.
Lindholm JS; Autio H; Vesa L; Antila H; Lindemann L; Hoener MC; Skolnick P; Rantamäki T; Castrén E
Neuropharmacology; 2012 Jan; 62(1):391-7. PubMed ID: 21867718
[TBL] [Abstract][Full Text] [Related]
8. Rapid and sustained restoration of astrocytic functions by ketamine in depression model mice.
Ma X; Yang S; Zhang Z; Liu L; Shi W; Yang S; Li S; Cai X; Zhou Q
Biochem Biophys Res Commun; 2022 Aug; 616():89-94. PubMed ID: 35653826
[TBL] [Abstract][Full Text] [Related]
9. TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats.
Hara H; Suzuki A; Kunugi A; Tajima Y; Yamada R; Kimura H
Pharmacol Biochem Behav; 2021 Dec; 211():173289. PubMed ID: 34655652
[TBL] [Abstract][Full Text] [Related]
10. Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine.
Deyama S; Duman RS
Pharmacol Biochem Behav; 2020 Jan; 188():172837. PubMed ID: 31830487
[TBL] [Abstract][Full Text] [Related]
11. Increased vulnerability to depressive-like behavior of mice with decreased expression of VGLUT1.
Garcia-Garcia AL; Elizalde N; Matrov D; Harro J; Wojcik SM; Venzala E; Ramírez MJ; Del Rio J; Tordera RM
Biol Psychiatry; 2009 Aug; 66(3):275-82. PubMed ID: 19409534
[TBL] [Abstract][Full Text] [Related]
12. Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex.
Zhou W; Wang N; Yang C; Li XM; Zhou ZQ; Yang JJ
Eur Psychiatry; 2014 Sep; 29(7):419-23. PubMed ID: 24321772
[TBL] [Abstract][Full Text] [Related]
13. Reduction of BDNF Levels and Biphasic Changes in Glutamate Release in the Prefrontal Cortex Correlate with Susceptibility to Chronic Stress-Induced Anhedonia.
Hu X; Zhao HL; Kurban N; Qin Y; Chen X; Cui SY; Zhang YH
eNeuro; 2023 Nov; 10(11):. PubMed ID: 37989582
[TBL] [Abstract][Full Text] [Related]
14. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress.
Chiu CT; Scheuing L; Liu G; Liao HM; Linares GR; Lin D; Chuang DM
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548109
[TBL] [Abstract][Full Text] [Related]
15. Partial mGlu
Pałucha-Poniewiera A; Rafało-Ulińska A; Santocki M; Babii Y; Kaczorowska K
Pharmacol Rep; 2024 Jun; 76(3):504-518. PubMed ID: 38632187
[TBL] [Abstract][Full Text] [Related]
16. Nucleocytoplasmic export of HDAC5 and SIRT2 downregulation: two epigenetic mechanisms by which antidepressants enhance synaptic plasticity markers.
Muñoz-Cobo I; Erburu MM; Zwergel C; Cirilli R; Mai A; Valente S; Puerta E; Tordera RM
Psychopharmacology (Berl); 2018 Oct; 235(10):2831-2846. PubMed ID: 30091005
[TBL] [Abstract][Full Text] [Related]
17. A key role of miR-132-5p in the prefrontal cortex for persistent prophylactic actions of (R)-ketamine in mice.
Ma L; Wang L; Chang L; Shan J; Qu Y; Wang X; Wan X; Fujita Y; Hashimoto K
Transl Psychiatry; 2022 Sep; 12(1):417. PubMed ID: 36171191
[TBL] [Abstract][Full Text] [Related]
18. Role of neurotrophic and growth factors in the rapid and sustained antidepressant actions of ketamine.
Deyama S; Kaneda K
Neuropharmacology; 2023 Feb; 224():109335. PubMed ID: 36403852
[TBL] [Abstract][Full Text] [Related]
19. Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies.
Pham TH; Gardier AM
Pharmacol Ther; 2019 Jul; 199():58-90. PubMed ID: 30851296
[TBL] [Abstract][Full Text] [Related]
20. Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2
Fukumoto K; Fogaça MV; Liu RJ; Duman C; Kato T; Li XY; Duman RS
Proc Natl Acad Sci U S A; 2019 Jan; 116(1):297-302. PubMed ID: 30559184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
